Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Huana Kangle Pharmaceutical is a Chinese pharmaceutical company specializing in the manufacturing and distribution of finished dosage forms and active pharmaceutical ingredients (APIs). As a subsidiary of Hunan Huana Pharmaceutical Co., Ltd., the company focuses on a broad range of therapeutic areas including analgesics, antipyretics, and gastrointestinal treatments. Their product portfolio features well-known generic medications such as paracetamol and various proton pump inhibitors. The company operates modern manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to ensure high-quality production for both domestic and international markets. Hunan Huana Kangle Pharmaceutical plays a significant role in the supply chain of essential medicines within the Hunan province and across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Huana Kangle Pharmaceutical.